Award
Delivery Order #SPE2DR26FMM7H
AmerisourceBergen Awarded Delivery Order for Quillivant XR Pharmaceutical
Buyer
Defense Logistics Agency
Award Amount
$623.95
Ceiling
$623.95
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FMM7H
NAICS
424210
This award represents a delivery order contract under an ongoing indefinite delivery vehicle held by AmerisourceBergen Drug Corp. The recipient, a leading pharmaceutical distributor, is tasked with supplying Quillivant XR, a medication suspension, highlighting its role in ensuring timely pharmaceutical delivery to government facilities. The contract is significant as it supports the government's healthcare supply chain by procuring essential medications efficiently. The scope involves providing a specific pharmaceutical product in precise dosage and volume. This delivery order was issued within a competitive framework under the existing long-term contract with AmerisourceBergen, which manages comprehensive pharmaceutical distribution services. The short-term performance period reflects a prompt fulfillment requirement, reinforcing the contract's role in immediate medical supply needs. The contract contributes to maintaining uninterrupted access to vital medications for government health operations, underpinning public health and safety objectives.
Description
4571084097!QUILLIVANT XR 25 MG/5 ML SUSP 180ML